Our Recommendations
- Consolidated HIV guidelines for prevention, treatment, service delivery & monitoring (2021)
- Consolidated guidelines on the Use of Antiretroviral Drugs for Treating and Preventing HIV Infection (2016)
- Guidelines: updated recommendations on HIV prevention, infant diagnosis, antiretroviral initiation and monitoring (2021)
- Manual for male circumcision under local anaesthesia and HIV prevention services for adolescent boys and men (2018)
- Updated Recommendations Onservice Delivery For The Treatment And Care Of People Living With HIV. Summary Slides (2021)
New Publications
- Identifying common opportunistic infections among people with advanced HIV disease (2024)
- Leveraging the Learning Insights from HIV Programming for Pregnant and Parenting Adolescent Girls (2023)
- Laboratory and point-of-care diagnostic testing for sexually transmitted infections, including HIV (2023)
- Point-of-care tests for sexually transmitted infections: target product profiles (2023)
- The role of HIV viral suppression in improving individual health and reducing transmission (2023)
Filter
337
Featured
Recommendations
13
New Publications
79
Language
Document type
No document type
120
Guidelines
112
Studies & Reports
59
Fact sheets
22
Infographics
9
Manuals
5
Situation Updates
3
Training Material
2
Resource Platforms
2
Brochures
1
Online Courses
1
Strategic & Response Plan
1
Countries / Regions
Latin America and the Carribbean
7
South Africa
7
Global
5
Africa
5
East and Southern Africa
5
Malawi
3
Asia
3
South–East Asia Region
3
Western and Central Europe
3
Uganda
3
Kenya
2
Lesotho
2
USA
2
Zambia
2
Nepal
1
El Salvador
1
Syria
1
Laos
1
Afghanistan
1
Zimbabwe
1
Philippines
1
Mozambique
1
Cambodia
1
Guinea-Bissau
1
Congo, Democratic Republic of
1
Middle East and North Africa
1
Western Pacific Region
1
North America
1
Jamaica
1
Bangladesh
1
Vietnam
1
Brazil
1
Sri Lanka
1
Russia
1
Yemen
1
Angola
1
Bhutan
1
India
1
Pakistan
1
Authors & Publishers
Publication Years
Category
HIV & STI
38
Policies & Guidelines HIV & TB
8
TB
8
Guidelines
7
Reproductive Health
6
Studies & Reports
5
Hepatitis
3
COVID-19
3
Women & Child Health
3
Capacity Building
3
Gynaecology & Obstetrics
3
Dermatology
2
Virology
2
Family Planning
1
x MEDBOX Issue Brief & Annual Reports x
1
Cervical Cancer
1
Chagas
1
Training Manuals
1
Demograhic Health Surveys DHS
1
Community Health
1
Information, Education and Communication (IEC)
1
Surgery & Anaesthesia
1
Nutrition
1
Maternal Health
1
Leishmaniasis
1
Non-communicable Diseases
1
Pharmacy & Technologies
1
Toolboxes
HIV testing & services
55
Clinical Aspects, Treatment & Prevention
49
Antiretroviral Treatment ART
46
Women
38
Clinical Aspects
36
Postexposure Prophylaxis (PEP), Pre-Exposure Prophylaxis (PrEP)
35
ART Drug Resistance
25
Male Circumcision
23
HIV and COVID-19
23
COVID-19
22
Treatment Guidelines HIV
21
Opportunistic Infections
19
Prevention Guidelines
17
HIV service delivery
16
Access to treatment and laboratory
15
Co-Morbidities (except TB)
15
Treatment & Prevention
14
Policies
10
Prophylactic Treatment
10
Adherence
9
Testing Guidelines
8
Global Impact: Socio-economic, health services, TB & HIV
7
General Reports
6
Children & Adolescents
5
Community Worker
5
Eastern and Southern Africa
5
Drug resistance
4
Prevention of mother-to-child transmission (PMTCT)
4
Latin America & the Carribean
4
Others
3
Immunization Guidelines
3
Health Worker
3
Policies and guidelines
3
HIV in Key Populations
3
Eastern Europe and central Asia
3
Policies & Strategies
2
Prevention & Control
2
Global
2
Laboratory
2
Universal Health Coverage UHC and 90-90-90 Strategy
2
Country specific documents
2
Gender Aspects
2
TB/HIV
2
Asia and Pacific
2
HIV and coinfection
2
TB/HIV Coinfection
2
Reports & Studies Children HIV
2
Drugs
1
Adults
1
HIV surveillance
1
Substance Use Disorders, Others
1
Inclusion
1
HIV testing & disclosure
1
Transgender People
1
Sexually Transmitted Infections
1
Men who have sex with men (MSM)
1
HIV
1
People who injecting Drugs
1
HIV / AIDS
1
Reports
1
General
1
Clinical Guidelines
1
Online Courses & Resources
1
For Pregnant Women
1
Training, others
1
For Migrants & Refugees
1
Prison & Detention
1
For Older People
1
Hospital Readiness/Essential Health Services
1
COVID-19 Vaccination
1
Long-term Care Facilities
1
TB/COVID-19
1
Community Health Workers CHW
1
HIV &TB
1
Information Refugees Ukraine
1
Zoonoses
1
NTDs
1
Chagas
1
Clinical Aspects & Diagnostics
1
General Aspects
1
Malawi
1
For Community Health Workers
1
Nutrition
1
Research & Access
1
TB
1
Lobby and Advocacy
1
Depression
1
Prisoners
1
These consolidated guidelines on HIV testing services (HTS) bring together existing and new guidance on HTS across different settings and populations.
The World Health Organization (WHO) first released consolidated guidelines on HTS in 2015, in response to requests from Member States, national pr...
The aim of the operational framework is to ensure 1) accurate collection, handling, shipment and storage of specimens collected in countries implementing HIV drug resistance surveillance; and 2) the availability of quality-assured HIV genotyping laboratory services producing comparable and reliable ...
Version 10.1_5 October 2020
These Guidelines are available in different formats: As a paper booklet, a PDF, a mobile app, and now also as a website.
The 2019 version of the Guidelines introduces a new drug-drug interaction panel and now consists of six main sections, including a general overview ...
WHO recommends that pre-exposure prophylaxis (PrEP) be offered as an additional prevention choice for HIV-negative individuals at substantial risk of HIV infection as part of combination prevention approaches.
HIV drug resistance has been rarely reported among PrEP users who tested HIV positive i...
In the time of coronavirus disease (COVID-19), sex and drug use will continue, regardless of physical distancing orders and policies. People who previously met in community gathering venues such as bars and clubs may now meet in different sites, ones that are “hidden” or less accessible. This, i...
The COVID-19 pandemic is rapidly spreading across the world and including countries affected by other infectious disease epidemics, such as HIV, tuberculosis (TB) and malaria. Over the past three decades, the global HIV response has gained experience in developing effective prevention approaches. Th...
The aim of this brief is to ensure that the COVID-19 pandemic does not disrupt the supply of and demand generation for condoms. Sexual relations may be transformed in the new context of the pandemic, but they have not stopped. While access to male and female condoms has been critical in the global r...
COVID-19 is a serious disease and all people living with HIV should take all recommended preventive measures to minimize exposure to, and prevent infection by, the virus that causes COVID-19. As in the general population, older people living with HIV or people living with HIV with heart or lung prob...
This programmatic brief explores how to expand HIV and STI prevention and contraceptive method options in contraceptive services and, thus, to reduce HIV and STI incidence among adolescent girls and women. It focuses on settings with extremely high HIV prevalence and incidence. This brief complement...
The COVID-19 pandemic has exposed the inadequacy of investments in public health, the persistence of profound economic and social inequalities and the fragility of many key global systems and approaches.
Результаты исследования «Изучение распространенности коронавирусной инфекции COVID-19 среди инфицированных ВИЧ пациентов вРоссии ивлияния эпидемии коронавирусной...
This fourth progress report November 2020 of the Global HIV Prevention Coalition reviews the progress in the 28 focus countries and complements the three previous progress reports. This report describes key developments in 2019–2020, identifies challenges and opportunities (including those associa...
12 January 2021
The COVID-19 vaccines under development or approved by regulators are believed to be safe for most people, including people living with HIV.
This document is also available in Arabic and Portuguese.
12 January 2021
The COVID-19 vaccines under development or approved by regulators are believed to be safe for most people, including people living with HIV.
The COVID-19 pandemic arrived in an evolving epidemiological context where some countries are experiencing a progressive decrease in HIV positivity in their testing programme as they are moving closer to the first 95 target. Distinguishing changes in HIV testing services due to the COVID-19 pandemic...
Se sabe desde hace tiempo que las mujeres con el VIH presentan un mayor riesgo de desarrollar cáncer cervicouterino; sin embargo, existen pocos datos e información sobre esta afección en la Región de las Américas. Este estudio, realizado entre el 2019 y el 2020, intenta brindar información y d...
This technical note summarizes the consolidated guidelines and adapts them to the context of Latin America and the Caribbean, in order to adequately monitor the number of people on ART. For this purpose, guidance is presented on the indicators and the methodology to know more precisely the number of...
